Clinical Trial Information Request for Protocol 21-059 Title A Phase 1/2 study of Acalabrutinib in recurrent or refractory Central Nervous System Lymphoma (CNSL) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone